| ACOR |    | Acorda Therapeutics, Inc. - Common Stock | | | 8.75% 8.75% 0 | | + Disease: Neurology/Alzheimer/Parkinson's, Medicine, Biotechnology
Last highlighted: Form 8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain.. $ACOR https://t.co/pzylSpmKBK | + My List |
| APTO | | Aptose Biosciences, Inc. - Common Shares | | | 6.53% down 7.56% -1.03 | | + Biotechnology
| + My List |
| APVO | | Aptevo Therapeutics Inc. - Common Stock | | | 6.47% down 8.18% -1.71 | | + Biotechnology, Medicine, Disease: Oncology, Immunology
Last highlighted: $APVTW [15s. delayed] filed form 8-K on May 27, 09:02:28: Item7.01: Regulation FD https://t.co/MpE2r05xab | + My List |
| BNTC | | Benitec Biopharma Inc. - Common Stock | | | 2.94% down 13.37% -10.43 | | + Biopharma, Biotechnology, RNA, Medicine, Gene and cell
Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q | + My List |
| BNTX | | BioNTech SE - American Depositary Shares | | | 3.06% down 11.04% -7.98 | | + Biotechnology, Immunology, Covid (fighting), Medicine
Last highlighted: #BNTX SEC report: BioNTech SE Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BioNTech SE -- SEC File Number 211142358 | + My List |
| CYCC | | Cyclacel Pharmaceuticals, Inc. - Common Stock | | | -4.93% down 9.09% -14.02 | | + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
| + My List |
| DARE | | Dare Bioscience, Inc. - Common Stock | | | 1.81% 1.81% 0 | | + Biotechnology, Healthcare, Women Health
Last highlighted: SEC Form 8-K [Press/News Current Report] filed by $DARE Dare Bioscience, Inc. https://t.co/iSB0Q2Ucpd | + My List |
| ENTX | | Entera Bio Ltd. - Ordinary Shares | | | 1.74% 1.74% 0 | | + Country: Israel, Biotechnology, Pharmaceutical
Last highlighted: $ENTX 📜 SEC Form 6-K filed by Entera Bio Ltd.
https://t.co/dws8IKVGAV
#healthcare | + My List |
| ENTXW | | Entera Bio Ltd. - Warrant | | | up -10.78% 10.78 | | + Country: Israel, Biotechnology, Pharmaceutical
| + My List |
| FBIO | | Fortress Biotech, Inc. - Common Stock | | | 6.9% down 7.59% -0.69 | | + Pharmaceutical , Biopharma, Biotechnology, Medicine
| + My List |
| FBIOP | | Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | | | -0.43% -0.43% 0 | | + Medicine, Biotechnology, Biopharma
| + My List |
| FLDM | | Fluidigm Corporation - Common Stock | | | 6.42% down 7.82% -1.4 | | + Life Sciences, Biology, Cancer fight, Biotechnology, RNA
Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270 | + My List |
| FRLN | | Freeline Therapeutics Holdings plc - ADSs | | | 2.91% down 7.67% -4.76 | | + Medicine, Biotechnology, Gene and cell
| + My List |
| GLYC | | GlycoMimetics, Inc. - Common Stock | | | 0.85% down 7.73% -6.88 | | + Biotechnology, Medicine, Disease: Leukemia
| + My List |
| IGMS | | IGM Biosciences, Inc. - Common Stock | | | -7.01% up -7.33% 0.32 | | + Biotechnology, Gene and cell, Medicine
Last highlighted: #IGMS SEC report: IGM Biosciences, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IGM Biosciences, Inc. -- SEC File Number | + My List |
| IMNM | | Immunome, Inc. - Common Stock | | | 12.2% 12.2% 0 | | + Cancer fight, Biotechnology, Medicine, Immunology
| + My List |
| IMRN | | Immuron Limited - American Depositary Shares | | | 9.83% 9.83% 0 | | + Biotechnology, Country: Australia, Biopharma, Medicine
Last highlighted: $IMRN 📜 SEC Form 6-K filed by Immuron Limited
https://t.co/xsrBOQcQ0a | + My List |
| IOVA | | Iovance Biotherapeutics, Inc. - Common Stock | | | -0.67% down 10.03% -10.7 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127 | + My List |
| KIN | | Kindred Biosciences, Inc. - Common Stock | | | 45.43% down 45.74% -0.31 | | + Animals, Biopharma, Biotechnology, Medicine, Pets
Last highlighted: #KIN SEC report: Kindred Biosciences, Inc. Definitive proxy statement relating to merger or acquisition
SEC Filing Form DEFM14A filed by Kindred Biosciences, Inc. -- SEC File Number 211102924 | + My List |
| LRMR | | Larimar Therapeutics, Inc. - Common Stock | | | -8.79% -8.79% 0 | | + Medicine, Gene and cell, Biotechnology
| + My List |
| MBRX | | Moleculin Biotech, Inc. - Common Stock | | | 6.57% down 7.14% -0.57 | | + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious
Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities | + My List |
| MCRB | | Seres Therapeutics, Inc. - Common Stock | | | 1.24% down 13.87% -12.63 | | + Medicine, Microbiome, Biotechnology
Last highlighted: #MCRB SEC report: Seres Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Seres Therapeutics, Inc. -- SEC File Number 211137957 | + My List |
| NRIX | | Nurix Therapeutics, Inc. - Common stock | | | 6.06% down 8.27% -2.21 | | + Biotechnology, Cancer fight, Immunology
Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020 | + My List |
| NTLA | | Intellia Therapeutics, Inc. - Common Stock | | | -6.26% up -7.23% 0.97 | | + Medicine, Gene and cell, Biotechnology, Biopharma
| + My List |
| OMER | | Omeros Corporation - Common Stock | | | 0.88% down 8.34% -7.46 | | + Biopharma, Biotechnology, Medicine
Last highlighted: #OMER SEC report: OMEROS CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by OMEROS CORP -- SEC File Number | + My List |
| ONCR | | Oncorus, Inc. - Common Stock | | | -8.47% down -7.81% -0.66 | | + Cancer fight, Immunology, Biotechnology
Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316 | + My List |
| ORGS | | Orgenesis Inc. - Common Stock | | | -0.2% up -7% 6.8 | | + Biotechnology, Medicine, Gene and cell
Last highlighted: Filing Alert, FORM 10-Q [Quarterly Report] available. $ORGS #Orgenesis Inc. Orgenesis Inc https://t.co/cwDFhLgUnk | + My List |
| PDSB | | PDS Biotechnology Corporation - Common Stock | | | 4.86% down 7.35% -2.49 | | + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT | + My List |
| PRQR | | ProQR Therapeutics N.V. - Ordinary Shares | | | 0.77% up -7.62% 8.39 | | + Medicine, Biotechnology, Disease: Eye , RNA
| + My List |
| QRVO | | Qorvo, Inc. - Common Stock | | | -1.4% up -8.69% 7.29 | | + Semiconductor, Biotechnology, Diagnosing, IoT, 5G, Mobile, Network Infrastructure, Equipment
| + My List |
| RGNX | | REGENXBIO Inc. - Common Stock | | | 2.88% down 9.63% -6.75 | | + Gene and cell, Biotechnology, Medicine
| + My List |
| RKDA | | Arcadia Biosciences, Inc. - Common Stock | | | 7.02% up 6.58% 0.44 | | + Agritech, Biotechnology
Last highlighted: #RKDA SEC report: Arcadia Biosciences, Inc. [Amend] Current report, item 9.01
SEC Filing Form 8-K/A filed by Arcadia Biosciences, Inc. -- SEC File Number 211136758 | + My List |
| RLMD | | Relmada Therapeutics, Inc. - Common Stock | | | 1.08% 1.08% 0 | | + Disease: Central nervous system (CNS), Biotechnology, Medicine
Last highlighted: $RLMD 📜 SEC Form 10-Q filed by Relmada Therapeutics, Inc.
https://t.co/CGB5BcamVJ
30s delayed. This insight appeared in real-time at 🚆 https://t.co/TvhaBDQJ0C 🚆 | + My List |
| RVMD | | Revolution Medicines, Inc. - Common Stock | | | 3.5% up -8.48% 11.98 | | + Cancer fight, Medicine, Biotechnology
| + My List |
| SELB | | Selecta Biosciences, Inc. - Common Stock | | | 6.48% down 7.73% -1.25 | | + Biotechnology, Immunology, Biology, Medicine
Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS | + My List |
| SLRX | | Salarius Pharmaceuticals, Inc. - Common Stock | | | -0.97% -0.97% 0 | | + Cancer fight, Biotechnology, Medicine, Pharmaceutical
Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm)
📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
https://t.co/AWdEx2wgvD
#SLRX #8K #SalariusPharmaceuticals #News | + My List |
| SNES | | SenesTech, Inc. - Common Stock | | | 1.22% up -8.89% 10.11 | | + Biotechnology, Agritech
Last highlighted: $SNES SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers https://t.co/6t4UWwGDlL | + My List |
| TWST | | Twist Bioscience Corporation - Common Stock | | | 15.56% 15.56% 0 | | + Biotechnology, RNA, Medicine
Last highlighted: #TWST SEC report: Twist Bioscience Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Twist Bioscience Corp -- SEC File Number | + My List |
| WVE | | Wave Life Sciences Ltd. - Ordinary Shares | | | 2.55% up -10.59% 13.14 | | + Medicine, Biotechnology, Life Sciences
| + My List |
| XOMA | | XOMA Corporation - Common Stock | | | -12.53% up -12.57% 0.040000000000001 | | + Biotechnology, Medicine, Acquisitions/Investing
| + My List |
| YTEN | | Yield10 Bioscience, Inc. - Common Stock | | | 3.11% down 8.73% -5.62 | | + Biotechnology, Agritech, Food
| + My List |
| AGFY | | Agrify Corporation - Common Stock | | | 8.46% 8.46% 0 | | + Biotechnology, Cannabis, Farm, Agritech
| + My List |
| ENVB | | Enveric Biosciences, Inc. - Common Stock | | | -10.24% down -4.78% -5.46 | | + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology
Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155 | + My List |
| EVAX | | Evaxion Biotech A/S - American Depositary Share | | | -7.95% -7.95% 0 | | + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology
Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935 | + My List |
| GBS | | GBS Inc. - Common Stock | | | 6.45% down 8.5% -2.05 | | + Medicine, Biotechnology
| + My List |
| IDBA | | IDEX Biometrics ASA - American Depositary Shares | | | -2.46% up -7.02% 4.56 | | + Technology, Security, Biotechnology, Fingerprint
| + My List |
| LGVN | | Longeveron Inc. - common stock | | | -2.67% up -8% 5.33 | | + Biotechnology, Medicine, Gene and cell, Disease: Neurology/Alzheimer/Parkinson's
| + My List |
| LIXT | | Lixte Biotechnology Holdings, Inc. - Common Stock | | | 1.78% up -7.41% 9.19 | | + Biotechnology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663 | + My List |
| RXDX | | Prometheus Biosciences, Inc. - Common Stock | | | 7.7% down 8.02% -0.32 | | + Biotechnology, Medicine, Diagnosing, Immunology
| + My List |
| VRDN | | Viridian Therapeutics, Inc. - Common Stock | | | 0.00% 0 | | + Disease: Eye , Medicine, Biotechnology
Last highlighted: $VRDN 8-K/A Viridian Therapeutics (15 Jun, 5:30pm)
📰 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (amendment)
https://t.co/Ot2kOEW3mb
#VRDN #8KA #ViridianTherapeutics #News | + My List |